Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic
SAN MATEO, Calif., Dec. 04, 2023 -- Sagimet Biosciences Inc. , a clinical-stage biopharmaceutical company developing novel fatty acid synthase inhibitors that target dysfunctional metabolic...